Health & Life (1781) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 合世

Health & Life (1781) reported revenue of NT$19.5 million for Oct 2026, -42.3% year on year and -29.0% from the previous month. Revenue for Jan–Oct 2026 was NT$290.6 million (-7.7% year on year).

In Oct 2026, it ranked No. 125 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$60.9 million24/10Nov 2024 NT$48.1 millionDec 2024 NT$52.1 millionJan 2025 NT$52.5 millionFeb 2025 NT$30.1 million25/02Mar 2025 NT$39.5 millionApr 2025 NT$22.9 millionMay 2025 NT$21.2 millionJun 2025 NT$25.1 million25/06Jul 2025 NT$44.2 millionAug 2025 NT$21.9 millionSep 2025 NT$23.5 millionOct 2025 NT$33.9 million25/10Nov 2025 NT$38.7 millionDec 2025 NT$44.7 millionJan 2026 NT$37.1 millionFeb 2026 NT$32.4 million26/02Mar 2026 NT$27.5 millionApr 2026 NT$22.2 millionMay 2026 NT$40.1 millionJun 2026 NT$34.1 million26/06Jul 2026 NT$21.1 millionAug 2026 NT$29.1 millionSep 2026 NT$27.5 millionOct 2026 NT$19.5 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$19.5 million-42.3%-29.0%
Sep 2026NT$27.5 million+17.2%-5.5%
Aug 2026NT$29.1 million+33.2%+38.1%
Jul 2026NT$21.1 million-52.3%-38.1%
Jun 2026NT$34.1 million+36.0%-14.8%
May 2026NT$40.1 million+89.1%+80.7%
Apr 2026NT$22.2 million-3.2%-19.3%
Mar 2026NT$27.5 million-30.4%-15.2%
Feb 2026NT$32.4 million+7.7%-12.7%
Jan 2026NT$37.1 million-29.4%-17.0%
Dec 2025NT$44.7 million-14.2%+15.6%
Nov 2025NT$38.7 million-19.6%+14.0%
Oct 2025NT$33.9 million-44.3%+44.4%
Sep 2025NT$23.5 million-69.2%+7.3%
Aug 2025NT$21.9 million-74.2%-50.5%
Jul 2025NT$44.2 million-32.9%+76.2%
Jun 2025NT$25.1 million-30.3%+18.4%
May 2025NT$21.2 million-63.2%-7.5%
Apr 2025NT$22.9 million-1.3%-42.0%
Mar 2025NT$39.5 million-15.3%+31.3%
Feb 2025NT$30.1 million+1.2%-42.7%
Jan 2025NT$52.5 million-58.2%+0.8%
Dec 2024NT$52.1 million-5.3%+8.4%
Nov 2024NT$48.1 million+78.8%-21.0%
Oct 2024NT$60.9 million+79.5%-20.1%

Jan–Oct 2026 cumulative: NT$290.6 million (-7.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Health & Life vs PEC / Health & Life vs Lotus Pharm / Health & Life vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16